Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Paediatric IBD Porto Group of ESPGHAN"'
Autor:
Berger, Tal David, Lee, Huey Miin, Padmanaban, Lavenya Ramasamy, Wine, Eytan, Yerushalmy-Feler, Anat, Hojsak, Iva, Kazeka, Denis, Serban, Daniela Elena, Yogev, Dotan, Ledder, Oren, Lionetti, Paolo, Scarallo, Luca, Gasparetto, Marco, Croft, Nicholas M, Miele, Erasmo, Staiano, Annamaria, Meredith, Joseph, Aloi, Marina, Alvisi, Patrizia, Urlep, Darja, Weiss, Batia, Malham, Mikkel, Matar, Manar, Navas-López, Víctor Manuel, Romano, Claudio, Dipasquale, Valeria, Norsa, Lorenzo, Kolho, Kaija-Leena, Shamir, Raanan, Shouval, Dror S, Paediatric IBD Porto Group of ESPGHAN
Objectives: Adult studies suggest that patients with isolated colonic Crohn disease (L2 CD) exhibit unique characteristics differentiating them from patients with ileo-caecal (L1) CD and ulcerative colitis (UC). We aimed to characterize clinical feat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1659c6f8a61cf02c395e887488c71bf
https://helda.helsinki.fi/bitstream/10138/353918/1/Tal_et_al_Clinical_features_and_natural_history_of_pediatric_patients_with_ulcerative_proctitis.pdf
https://helda.helsinki.fi/bitstream/10138/353918/1/Tal_et_al_Clinical_features_and_natural_history_of_pediatric_patients_with_ulcerative_proctitis.pdf
Autor:
Turner D, Huang Y, Martín-de-Carpi J, Aloi M, Focht G, Kang B, Zhou Y, Sanchez C, Kappelman MD, Uhlig HH, Pujol G, Ledder O, Lionetti P, Dias JA, Ruemmele FM, Russell RK, Paediatric IBD Porto group of ESPGHAN
Publikováno v:
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
Introduction: With the current coronavirus disease 2019 (COVID-19) pandemic, concerns have been raised about the risk to children with inflammatory bowel diseases (IBD). We aimed to collate global experience and provide provisional guidance for manag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::c3ccb64619374e485654dcfa1b716d53
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=17542
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=17542
Autor:
Aloi, M., Dias, J.A., Huang, Y., Russell, R.K., Kappelman, M.D., Ruemmele, F.M., Uhlig, H.H., Lionetti, P., Mart¡n-de-Carpi, J., Turner, D., Pujol-Muncunill, G., Focht, G., Paediatric IBD Porto group of ESPGHAN, Zhou, Y., Sanchez, C., Ledder, O., Kang, B.
INTRODUCTION: With the current COVID-19 pandemic, concerns have been raised about the risk to children with inflammatory bowel diseases (IBD). We aimed to collate global experience and provide provisional guidance for managing paediatric IBD (PIBD) i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0e681fb1244048f23d87a6cb6705b2d7
Autor:
Paediatric IBD Porto Group of ESPGHAN, Joosse, M E, Aardoom, M A, Kemos, P, Turner, D, Wilson, D C, Koletzko, S, Martin-de-Carpi, J, Fagerberg, U L, Spray, C, Tzivinikos, C, Sladek, M, Shaoul, R, Roma-Giannikou, E, Bronsky, J, Serban, D E, Ruemmele, F M, Garnier-Lengline, H, Veres, G, Hojsak, I, Kolho, K L, Davies, I H, Aloi, M, Lionetti, P, Hussey, S, Veereman, G, Braegger, C P, Trindade, E, Wewer, A V, Hauer, A C, de Vries, A C H, Sigall Boneh, R, Sarbagili Shabat, C, Levine, A, de Ridder, L
Publikováno v:
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
Alimentary Pharmacology & Therapeutics, 48(5), 523-537. Wiley-Blackwell Publishing Ltd
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
Alimentary Pharmacology & Therapeutics, 48(5), 523-537. Wiley-Blackwell Publishing Ltd
Background: Risk benefit strategies in managing inflammatory bowel diseases (IBD) are dependent upon understanding the risks of uncontrolled inflammation vs those of treatments. Malignancy and mortality in IBD have been associated with disease-relate
Biologic therapies have changed the outcome of both adult and pediatric patients with Inflammatory Bowel Disease (IBD). In September 2013, the first biosimilar of infliximab was introduced into the pharmaceutical market. In 2015, a first position pap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10691::22625ffb77f5e446b575b84678ea8532
https://dspace.library.uu.nl/handle/1874/385573
https://dspace.library.uu.nl/handle/1874/385573
Autor:
Uhlig, Holm H., Charbit-Henrion, Fabienne, Kotlarz, Daniel, Shouval, Dror S., Schwerd, Tobias, Strisciuglio, Caterina, de Ridder, Lissy, van Limbergen, Johan, Macchi, Marina, Snapper, Scott B., Ruemmele, Frank M., Wilson, David C., Travis, Simon P. L., Griffiths, Anne M., Turner, Dan, Klein, Christoph, Muise, Aleixo M., Russell, Richard K., Paediatric IBD Porto group of ESPGHAN
Publikováno v:
Journal of Pediatric Gastroenterology & Nutrition; 2021, Vol. 72 Issue 3, p456-473, 18p
Autor:
Birimberg-Schwartz, Liron, Zucker, David M., Akriv, Amichay, Cucchiara, Salvatore, Cameron, Fiona L., Wilson, David C., Łazowska, Iza, Yianni, Lambri, Paul, Siba Prosad, Romano, Claudio, Kolacek, Sanja, Buderus, Stephan, Parregaard, Anders, Russell, Richard K., Escher, Johanna C., Turner, Dan, The Paediatric IBD Porto group of ESPGHAN, Sładek, Małgorzata
Publikováno v:
Journal of Crohn's and Colitis, 11(9), 1078-1084. Oxford University Press
markdownabstract__Background:__ The revised Porto criteria identify subtypes of paediatric inflammatory bowel diseases: ulcerative colitis [UC], atypical UC, inflammatory bowel disease unclassified [IBDU], and Crohn's disease [CD]. Others have propos
Autor:
Turner, Dan, Ying Huang, Martín-de-Carpi, Javier, Aloi, Marina, Focht, Gili, Ben Kang, Ying Zhou, Sanchez, Cesar, Kappelman, Michael D., Uhlig, Holm H., Pujol-Muncunill, Gemma, Ledder, Oren, Lionetti, Paolo, Dias, Jorge Amil, Ruemmele, Frank M., Russell, Richard K., Huang, Ying, Kang, Ben, Zhou, Ying, Paediatric IBD Porto group of ESPGHAN
Publikováno v:
Journal of Pediatric Gastroenterology & Nutrition; Jun2020, Vol. 70 Issue 6, p727-733, 7p
Autor:
Birimberg-Schwartz, Liron, Wilson, David, Kolho, Kaija-Leena, Karolewska-Bochenek, Katarzyna, Nadeem Ahmad, Afzal, Spray, Christine, Romano, Claudio, Lionetti, Paolo, Hauer, Almuthe, Martinez-Vinson, Christine, Veres, Gabor, Escher, Johanna, Turner, Dan, The Paediatric IBD Porto group of ESPGHAN, Sładek, Małgorzata
Publikováno v:
Inflammatory Bowel Diseases, 22(8), 1908-1914. Oxford University Press
Introduction No study to date has evaluated perinuclear antineutrophil cytoplasmic antibody (pANCA) and anti-Saccharomyces cerevisiae antibody (ASCA) in pediatric inflammatory bowel disease-unclassified (IBDU) as compared with Crohn's colitis (CC) an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa517c236480719bb8bb37acb308e173
https://ruj.uj.edu.pl/xmlui/handle/item/97015
https://ruj.uj.edu.pl/xmlui/handle/item/97015
Autor:
Dwight A., Winter, Karolewska-Bochenek, Katarzyna, Lazowska-Przeorek, Izabella, Lionetti, Paolo, Mearin, M. Luisa, Chong, Sonny K., Roma-Giannikou, Eleftheria, Maly, Jan, Kolho, Kaija-Leena, Shaoul, Ron, Staiano, Annamaria, Damen, Gerard M., de Meij, Tim, Hendriks, Danielle, George, Elvira K., Turner, Dan, Escher, Johanna C., The Paediatric IBD Porto group of ESPGHAN, Sładek, Małgorzata
Publikováno v:
Inflammatory Bowel Diseases, 21, 9, pp. 2145-2153
Inflammatory Bowel Diseases, 21, 2145-2153
Inflammatory Bowel Diseases, 21(9), 2145-2153. John Wiley and Sons Inc.
Inflammatory Bowel Diseases, 21(9), 2145-2153
Inflammatory Bowel Diseases, 21(9), 2145-2153. Oxford University Press
Winter, D A, Karolewska-Bochenek, K, Lazowska-Przeorek, I, Lionetti, P, Mearin, M L, Chong, S K, Roma-Giannikou, E, Maly, J, Kolho, K L, Shaoul, R, Staiano, A, Damen, G M, de Meij, T G J, Hendriks, D, George, E K, Turner, D & Escher, J C 2015, ' Pediatric IBD-unclassified Is Less Common than Previously Reported; Results of an 8-Year Audit of the EUROKIDS Registry ', Inflammatory Bowel Diseases, vol. 21, no. 9, pp. 2145-2153 . https://doi.org/10.1097/MIB.0000000000000483
Inflammatory Bowel Diseases, 21, 2145-2153
Inflammatory Bowel Diseases, 21(9), 2145-2153. John Wiley and Sons Inc.
Inflammatory Bowel Diseases, 21(9), 2145-2153
Inflammatory Bowel Diseases, 21(9), 2145-2153. Oxford University Press
Winter, D A, Karolewska-Bochenek, K, Lazowska-Przeorek, I, Lionetti, P, Mearin, M L, Chong, S K, Roma-Giannikou, E, Maly, J, Kolho, K L, Shaoul, R, Staiano, A, Damen, G M, de Meij, T G J, Hendriks, D, George, E K, Turner, D & Escher, J C 2015, ' Pediatric IBD-unclassified Is Less Common than Previously Reported; Results of an 8-Year Audit of the EUROKIDS Registry ', Inflammatory Bowel Diseases, vol. 21, no. 9, pp. 2145-2153 . https://doi.org/10.1097/MIB.0000000000000483
Background: Inflammatory bowel disease-unclassified (IBD-U) is diagnosed in ∼10% of pediatric and adolescent onset IBD patients. The EUROKIDS registry (2004) initiated by the Porto IBD working group of ESPGHAN prospectively monitors diagnostic work
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::481cdfa5902127b7ac4a419bcc3fc758
https://hdl.handle.net/2066/153615
https://hdl.handle.net/2066/153615